ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/08/16 | 1,355 | 1,359 | 1,355 | 1,358 | +4 | +0.3% | 12,000 |
| 2012/08/15 | 1,344 | 1,354 | 1,342 | 1,354 | +9 | +0.7% | 18,000 |
| 2012/08/14 | 1,335 | 1,345 | 1,335 | 1,345 | +11 | +0.8% | 4,000 |
| 2012/08/13 | 1,317 | 1,334 | 1,317 | 1,334 | +18 | +1.4% | 3,000 |
| 2012/08/10 | 1,305 | 1,318 | 1,305 | 1,316 | -30 | -2.2% | 8,000 |
| 2012/08/09 | 1,292 | 1,350 | 1,271 | 1,346 | +84 | +6.7% | 24,000 |
| 2012/08/08 | 1,292 | 1,292 | 1,260 | 1,262 | -34 | -2.6% | 9,000 |
| 2012/08/07 | 1,300 | 1,300 | 1,296 | 1,296 | +18 | +1.4% | 2,000 |
| 2012/08/06 | 1,266 | 1,280 | 1,266 | 1,278 | +12 | +0.9% | 11,000 |
| 2012/08/03 | 1,265 | 1,267 | 1,265 | 1,266 | -23 | -1.8% | 7,000 |
| 2012/08/02 | 1,310 | 1,310 | 1,270 | 1,289 | -35 | -2.6% | 17,000 |
| 2012/08/01 | 1,329 | 1,329 | 1,316 | 1,324 | -15 | -1.1% | 4,000 |
| 2012/07/31 | 1,350 | 1,376 | 1,335 | 1,339 | -12 | -0.9% | 19,000 |
| 2012/07/30 | 1,338 | 1,351 | 1,326 | 1,351 | +14 | +1% | 10,000 |
| 2012/07/27 | 1,351 | 1,351 | 1,337 | 1,337 | -24 | -1.8% | 14,000 |
| 2012/07/26 | 1,374 | 1,376 | 1,361 | 1,361 | -12 | -0.9% | 8,000 |
| 2012/07/25 | 1,379 | 1,389 | 1,372 | 1,373 | -1 | -0.1% | 25,000 |
| 2012/07/24 | 1,355 | 1,385 | 1,355 | 1,374 | +12 | +0.9% | 7,000 |
| 2012/07/23 | 1,361 | 1,378 | 1,361 | 1,362 | -8 | -0.6% | 13,000 |
| 2012/07/20 | 1,363 | 1,378 | 1,363 | 1,370 | -10 | -0.7% | 4,000 |
| 2012/07/19 | 1,373 | 1,387 | 1,373 | 1,380 | +7 | +0.5% | 11,000 |
| 2012/07/18 | 1,390 | 1,390 | 1,368 | 1,373 | -4 | -0.3% | 5,000 |
| 2012/07/17 | 1,370 | 1,390 | 1,359 | 1,377 | +3 | +0.2% | 11,000 |
| 2012/07/13 | 1,380 | 1,380 | 1,354 | 1,374 | +4 | +0.3% | 7,000 |
| 2012/07/12 | 1,379 | 1,379 | 1,367 | 1,370 | -8 | -0.6% | 8,000 |
| 2012/07/11 | 1,400 | 1,400 | 1,378 | 1,378 | -17 | -1.2% | 4,000 |
| 2012/07/10 | 1,379 | 1,420 | 1,379 | 1,395 | +46 | +3.4% | 27,000 |
| 2012/07/09 | 1,345 | 1,365 | 1,345 | 1,349 | -21 | -1.5% | 10,000 |
| 2012/07/06 | 1,379 | 1,383 | 1,354 | 1,370 | +6 | +0.4% | 9,000 |
| 2012/07/05 | 1,367 | 1,387 | 1,364 | 1,364 | -3 | -0.2% | 7,000 |
| 2012/07/04 | 1,352 | 1,371 | 1,348 | 1,367 | +15 | +1.1% | 8,000 |
| 2012/07/03 | 1,339 | 1,352 | 1,320 | 1,352 | +13 | +1% | 5,000 |
| 2012/07/02 | 1,365 | 1,365 | 1,335 | 1,339 | +4 | +0.3% | 8,000 |
| 2012/06/29 | 1,309 | 1,339 | 1,309 | 1,335 | +18 | +1.4% | 14,000 |
| 2012/06/28 | 1,325 | 1,325 | 1,312 | 1,317 | +3 | +0.2% | 14,000 |
| 2012/06/27 | 1,326 | 1,326 | 1,309 | 1,314 | +7 | +0.5% | 10,000 |
| 2012/06/26 | 1,336 | 1,347 | 1,307 | 1,307 | -12 | -0.9% | 13,000 |
| 2012/06/25 | 1,324 | 1,324 | 1,302 | 1,319 | -4 | -0.3% | 11,000 |
| 2012/06/22 | 1,336 | 1,336 | 1,320 | 1,323 | -10 | -0.8% | 9,000 |
| 2012/06/21 | 1,331 | 1,333 | 1,330 | 1,333 | +11 | +0.8% | 7,000 |
| 2012/06/20 | 1,303 | 1,327 | 1,303 | 1,322 | +9 | +0.7% | 18,000 |
| 2012/06/19 | 1,292 | 1,313 | 1,292 | 1,313 | +21 | +1.6% | 7,000 |
| 2012/06/18 | 1,243 | 1,292 | 1,243 | 1,292 | +36 | +2.9% | 15,000 |
| 2012/06/15 | 1,275 | 1,282 | 1,251 | 1,256 | -45 | -3.5% | 13,000 |
| 2012/06/14 | 1,295 | 1,301 | 1,288 | 1,301 | +13 | +1% | 12,000 |
| 2012/06/13 | 1,290 | 1,303 | 1,279 | 1,288 | -6 | -0.5% | 12,000 |
| 2012/06/12 | 1,252 | 1,294 | 1,252 | 1,294 | +25 | +2% | 11,000 |
| 2012/06/11 | 1,296 | 1,296 | 1,269 | 1,269 | +29 | +2.3% | 12,000 |
| 2012/06/08 | 1,256 | 1,277 | 1,220 | 1,240 | -10 | -0.8% | 69,000 |
| 2012/06/07 | 1,230 | 1,260 | 1,230 | 1,250 | +50 | +4.2% | 8,000 |
3001～
3050
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
